- Clinical Pharmacology
- Next »
Benztropine Mesylate
CLINICAL PHARMACOLOGY
Benztropine Mesylate
Benztropine mesylate possesses both anticholinergic and antihist-aminic effects, although only the former have been established as therapeutically significant in the management of parkinsonism.
In the isolated guinea pig ileum, the anticholinergic activity of this drug is about equal to that of atropine; however, when adminis-tered orally to unanesthetized cats, it is only about half as active as atropine.
In laboratory animals, its antihistaminic activity and duration of action approach those of pyrilamine maleate.
- Clinical Pharmacology
- Next »
« Previous: Benztropine Mesylate - Overdosage & Contraindications
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
WebMD Daily
Get breaking medical news.
Health Extras
Exercise and Parkinson's
While researchers chase a cure, patients wonder what will help now. Getting moving is one answer.See more WebMD Videos »
